American Society of Clinical Oncology Educational Book

American Society of Clinical Oncology

Evaluation status available after sign-in

About the journal

American Society of Clinical Oncology Educational Book is a journal published by American Society of Clinical Oncology in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
American Society of Clinical Oncology
ISSN
1548-8748 · 1548-8756
Country
United States
Access
Not open access / not declared

Index listings

  • MEDLINE · 2012-01-01
  • PUBMED · 2018-05-23
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1719

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

88

i10-index

962

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Open references deposited at Crossref
96%
ORCID iDs in current deposits
70%
Enrolled in Crossref Similarity Check
✓
Identity & continuity3
Alternate titles
American Society of Clinical Oncology educational bookASCO educational book
Source type
journal
NLM unique ID (PubMed)
101233985
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • CAR-T cell therapy research
  • CAR-T cell therapy research
Show all subjects (50)
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Palliative Care and End-of-Life Issues
  • Palliative Care and End-of-Life Issues
  • Cancer survivorship and care
  • Cancer survivorship and care
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Research Studies
  • Prostate Cancer Treatment and Research
  • Lung Cancer Research Studies
  • Prostate Cancer Treatment and Research
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Immunotherapy and Immune Responses
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Immunotherapy and Immune Responses
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Advances in Oncology and Radiotherapy
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Advances in Oncology and Radiotherapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: